Global Vaccine for Influenza Supply, Demand and Key Producers, 2023-2029

Global Vaccine for Influenza Supply, Demand and Key Producers, 2023-2029

The global Vaccine for Influenza market size is expected to reach $ 11570 million by 2029, rising at a market growth of 5.3% CAGR during the forecast period (2023-2029).

Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.

This report studies the global Vaccine for Influenza production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Vaccine for Influenza, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaccine for Influenza that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Vaccine for Influenza total production and demand, 2018-2029, (M Units)

Global Vaccine for Influenza total production value, 2018-2029, (USD Million)

Global Vaccine for Influenza production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (M Units)

Global Vaccine for Influenza consumption by region & country, CAGR, 2018-2029 & (M Units)

U.S. VS China: Vaccine for Influenza domestic production, consumption, key domestic manufacturers and share

Global Vaccine for Influenza production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (M Units)

Global Vaccine for Influenza production by Type, production, value, CAGR, 2018-2029, (USD Million) & (M Units)

Global Vaccine for Influenza production by Application production, value, CAGR, 2018-2029, (USD Million) & (M Units).

This reports profiles key players in the global Vaccine for Influenza market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and BCHT, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaccine for Influenza market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Vaccine for Influenza Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Vaccine for Influenza Market, Segmentation by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Global Vaccine for Influenza Market, Segmentation by Application
6 Months to 3 Years
> 3 Years

Companies Profiled:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Key Questions Answered

1. How big is the global Vaccine for Influenza market?

2. What is the demand of the global Vaccine for Influenza market?

3. What is the year over year growth of the global Vaccine for Influenza market?

4. What is the production and production value of the global Vaccine for Influenza market?

5. Who are the key producers in the global Vaccine for Influenza market?